Related Experiment Video
Updated: Jun 30, 2025
07:20
Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
Published on: May 28, 2014
14.0K
Exploiting Co(III)-Cyclopentadienyl Complexes To Develop Anticancer Agents
João Franco Machado1, Sandra Cordeiro2,3, Joana N Duarte1
1Centro de Química Estrutural, Institute of Molecular Sciences, Faculdade de Ciências, Universidade de Lisboa, Campo Grande, 1749-016 Lisboa, Portugal.
Inorganic Chemistry
|March 19, 2024
Summary
New cobalt(III)-cyclopentadienyl complexes show potent anticancer activity against colorectal, ovarian, and breast cancer cell lines by inducing cell death pathways. These novel organometallic compounds demonstrate promising therapeutic potential with no observed toxicity in vivo.
Area of Science:
- Organometallic Chemistry
- Medicinal Chemistry
- Cancer Therapeutics
Background:
- Platinum-based drugs face limitations in cancer treatment.
- Organometallic complexes offer alternative therapeutic strategies.
- Half-sandwich organometallic cobalt complexes are underexplored.
Purpose of the Study:
- Synthesize and characterize novel cobalt(III)-cyclopentadienyl complexes.
- Evaluate the in vitro cytotoxicity of these complexes against various human cancer cell lines.
- Investigate the in vivo toxicity and mechanism of action.
Main Methods:
- Synthesis and full characterization (elemental analysis, spectroscopy, DFT).
- In vitro cytotoxicity assessment using MTS assay (HCT116, A2780, MDA-MB-231, MCF-7 cell lines).
- In vivo toxicity evaluation using chick embryo yolk sac membrane (YSM) assay.
Main Results:
- Four new cobalt(III)-cyclopentadienyl complexes were successfully synthesized and characterized.
- High in vitro cytotoxicity was observed against colorectal, ovarian, and breast cancer cell lines.
- Mechanisms include ROS production, apoptosis, autophagy, and mitochondrial membrane disruption.
- No in vivo toxicity was detected in the chick embryo YSM assay.
Conclusions:
- The novel organometallic cobalt complexes exhibit significant anticancer potential.
- These complexes effectively induce cancer cell death through multiple pathways.
- Promising non-toxic therapeutic candidates for further investigation.
More Related Videos
Related Concept Videos
01:46Electron Transport Chain: Complex I and II
13.2K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
13.2K
01:16Cycloaddition Reactions: Overview
2.6K
Cycloadditions are one of the most valuable and effective synthesis routes to form cyclic compounds. These are concerted pericyclic reactions between two unsaturated compounds resulting in a cyclic product with two new σ bonds formed at the expense of π bonds. The [4 + 2] cycloaddition, known as the Diels–Alder reaction, is the most common. The other example is a [2 + 2] cycloaddition.
2.6K
02:39Positive Regulator Molecules
5.5K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.5K
02:34Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
01:16Cycloaddition Reactions: MO Requirements for Thermal Activation
3.6K
Thermal cycloadditions are reactions where the source of activation energy needed to initiate the reaction is provided in the form of heat. A typical example of a thermally-allowed cycloaddition is the Diels–Alder reaction, which is a [4 + 2] cycloaddition. In contrast, a [2 + 2] cycloaddition is thermally forbidden.
3.6K
01:17Pericyclic Reactions: Introduction
8.3K
Pericyclic reactions are organic reactions that occur via a concerted mechanism without generating any intermediates. The reactions proceed through the movement of electrons in a closed loop to form a cyclic transition state, where rearrangement of the σ and π bonds yields specific products.
Pericyclic reactions can be classified into three categories: electrocyclic reactions, cycloaddition reactions, and sigmatropic rearrangements. Electrocyclic reactions and sigmatropic...
Pericyclic reactions can be classified into three categories: electrocyclic reactions, cycloaddition reactions, and sigmatropic rearrangements. Electrocyclic reactions and sigmatropic...
8.3K